The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily ...

Here's what causes it. Regardless of what's causing the condition, COPD is treatable. "The mainstays of therapy have historically been inhaled bronchodilators and inhaled steroids," says Han.

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

It is Hawaii's largest robotic surgery centre for lung cancer treatment and will provide precision medicine tailored for each ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients ...